Margaret M Cary

Learn More
OBJECTIVES To evaluate the efficacy and tolerability of the selective alpha(1)-adrenergic antagonist doxazosin and the 5-alpha-reductase inhibitor finasteride, alone and in combination, for the symptomatic treatment of benign prostatic hyperplasia. METHODS In a prospective, double-blind, placebo-controlled trial, 1095 men aged 50 to 80 years were(More)
  • 1